PlainPharmaWatch

CMS Open Payments · Program Year 2024

Incyte Corporation

Incyte Corporation reported $84,406,436.77 in payments to 77,737 physicians and teaching hospitals across 109,620 transactions.

See the rankings → How this is sourced
$84.4M
Total payments
109,620
Transactions
77,737
Recipients
−$1.4M
General Payments vs PY2023

Incyte Corporation reported $84,406,436.77 in payments to 77,737 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #34 of 1,925 reporting manufacturers (0.6% of all US industry payments), averaging $1.1K per recipient across 10 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Incyte Corporation pairs top-5% payment volume with an unusually diversified payment pattern across a wide recipient base.

#34
of 1,925 companies
0.6%
of all US industry payments
0.1%
paid to its single top recipient
10
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Incyte Corporation's CMS-reported General Payments decreased by $1.4M (−9.7%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: INCYTE CORPORATIONPY2023: INCYTE CORPORATIONPY2024: Incyte Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$14.5MPY2024$13.1M
PY2023
$14,516,991.22
PY2024
$13,103,674.30

How Incyte Corporation ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Incyte Corporation's total vs. every reporting company

CMS Open Payments, Program Year 2024

$84,406,437 Top 2% higher than 98% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Below this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Below this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). This entry sits in this band. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Incyte Corporation

Incyte Corporation ranks #34 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, representing 0.6% of all industry payments reported nationwide for the year. The underlying total is $84,406,436.77 across 109,620 transactions to 77,737 physicians and teaching hospitals - $769.99 per transaction and $1.1K per recipient on average.

1,983 transactions worth $4.9M make "Compensation for Services Other Than Consulting" the top general-payment category in the 10-category breakdown below, 5.8% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads Incyte Corporation's 10-category general-payment breakdown at $4.9M, 5.8% of the reported total.

How Incyte Corporation divides its payments

General-payment categories, ordered by reported total

1. Compensation for Services…$4.9M2. Consulting Fee$2.6M3. Acquisitions$2.2M4. Food and Beverage$1.7M5. Travel and Lodging$862.5K6. Space Rental or Facility …$334.0K7. Education$305.4K8. Grant$145.0K9. Royalty or License$40.0K10. Charitable Contribution$6.4K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $4.9M 1,983
Consulting Fee $2.6M 622
Acquisitions $2.2M 4
Food and Beverage $1.7M 70,067
Travel and Lodging $862.5K 3,139
Space Rental or Facility Fees $334.0K 84
Education $305.4K 1,831
Grant $145.0K 3
Royalty or License $40.0K 2
Charitable Contribution $6.4K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $2,874,596.74 (21.9%) of $13,103,674.30 in this company's General Payments records across 20,131 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Incyte Corporation

The five named recipients with the highest reported General Payments from this company

Ethan Lerner$1.7MDanielle Petersel$460.5KSandra Lee$319.1KSerge Alexanian$276.2KAhmed Galal$140.6K
  1. 1

    Ethan Lerner

    $1,678,253.33 across 1 reported transactions

  2. 2

    Danielle Petersel

    $460,463.06 across 1 reported transactions

  3. 3

    Sandra Lee

    $319,108.75 across 22 reported transactions

  4. 4

    Serge Alexanian

    $276,158.61 across 31 reported transactions

  5. 5

    Ahmed Galal

    $140,612.99 across 107 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $769.99. Average per recipient: $1.1K.

Total Amount

$84,406,436.77

Avg per Transaction

$769.99

Avg per Recipient

$1.1K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Incyte Corporation Share

0.6%

#34 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Incyte Corporation

Servier BioInnovation

$83.4M 11 recipients

CSL Behring

$88.2M 27,644 recipients

Zimmer Biomet Holdings, Inc.

$88.6M 33,496 recipients

Celgene Corporation

$88.9M 60,850 recipients

BeiGene, Ltd.

$77.4M 57 recipients

Abbott Laboratories

$91.7M 292,558 recipients

Frequently Asked Questions

How much did Incyte Corporation pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $84,406,436.77 from Incyte Corporation to physicians and hospitals across 109,620 transactions - 0.6% of all industry payments reported that year.
How many physicians received payments from Incyte Corporation? ▾
77,737 physicians and teaching hospitals received payments from Incyte Corporation in 2024, averaging $1.1K per recipient.
What types of payments did Incyte Corporation make? ▾
10 categories of general payment make up Incyte Corporation's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $4.9M, representing 5.8% of the company's reported total.
How does Incyte Corporation rank among pharmaceutical companies? ▾
By total payment amount, Incyte Corporation sits at #34 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Incyte Corporation? ▾
The average transaction from Incyte Corporation was $769.99 in 2024. The company made 109,620 total transactions to 77,737 recipients.
Where does the payment data for Incyte Corporation come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Incyte Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.